Please Wait...
Please Wait...
Vultr's cloud GPUs enable faster innovation in biotech research
Vultr's solution, co-engineered with Dell Technologies, offers Athos agile infrastructure that adapts to evolving research needs. Dedicated engineering support, robust security, and user-friendly management tools eliminate on-premises constraints, allowing Athos to focus on innovation and unlock faster time-to-market.
Get started with
world’s largest privately-held cloud
infrastructure company
Athos + Vultr: Accelerating AI-Driven Drug Discovery
NVIDIA GPUs on Vultr accelerate Athos's AI, reduce costs, and ensure agile, secure research.
Athos Therapeutics sought a cloud solution to accelerate its AI-powered drug discovery for autoimmune diseases and cancer. Legacy clouds proved too costly and inflexible, hindering their ability to rapidly iterate on vast patient datasets.
Vultr, with NVIDIA HGX™ H100 GPUs, provides Athos with a scalable, secure, and cost-effective platform. This empowers Athos to develop next-generation treatments faster while safeguarding valuable intellectual property.
